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Respiratory Muscles, Exercise Performance and Health in
Overweight and Obese Subjects
Abstract
PURPOSE:: Overweight and obese subjects often perceive increased breathlessness during minor
exertion and therefore avoid exercise. Respiratory muscle endurance training (RMET) can reduce the
perception of breathlessness. We hypothesized that RMET one month prior to and during a 6-month
(3months supervised + 3months unsupervised) exercise and nutrition counseling program (EN) would
improve the benefits of EN. METHODS:: 26 overweight and obese subjects with significant perception
of breathlessness during exercise (age: 33+/-9y; body mass index [BMI]: 31.3+/-4.9kg.m) were
randomized to RMET+EN (R+EN) or EN alone. R+EN performed 30min of normocapnic hyperpnea
5wk prior to and 2wkduring EN. EN consisted of two strength and three endurance training sessions per
week, as well as prescribed nutritional composition and a 2.1kJ (=500kcal) energy deficit per day. Both
groups had an equal number of lab visits during the 7 months. Before, and after 4 and 7 months, subjects
performed a 12-min time trial (TT; 6+6min, 2min pause) and an incremental cycling test (ICT) to
exhaustion and blood lipids were assessed. RESULTS:: Weight loss was significant and similar in both
groups (-4.2 vs -3.7kg; both p<0.05). During the first 4 months, distance covered in 12min improved
more (p<0.05) with R+EN (1678 vs 1824m; p<0.001) than with EN alone (1638 vs 1698m; p<0.05),
while after R+EN, breathlessness during the ICT was reduced. Blood lipids of the pooled group
improved in those subjects with pathologic values before the study. Despite reduced training compliance
during the unsupervised period, subjects of both groups maintained the benefits attained during the
supervised period. CONCLUSION:: R+EN improved TT-performance more than EN alone, despite
similar weight loss, possibly due to reduced perception of breathlessness.
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ABSTRACT
Purpose: Overweight and obese subjects often perceive increased breathlessness during 
minor exertion and therefore avoid exercise. Respiratory muscle endurance training (RMET) can 
reduce the perception of breathlessness. We hypothesized that RMET one month prior to and 
during  a  6-month  (3months  supervised  +  3months  unsupervised)  exercise  and  nutrition 
counseling program (EN) would improve the benefits of EN. Methods: 26 overweight and obese 
subjects with significant perception of breathlessness during exercise (age: 33±9y; body mass 
index [BMI]:  31.3±4.9kg·m-2)  were  randomized  to  RMET+EN (R+EN) or  EN alone.  R+EN 
performed 30min of normocapnic hyperpnea 5wk-1 prior to and 2wk-1 during EN. EN consisted 
of two strength and three endurance training sessions per week, as well as prescribed nutritional 
composition and a 2.1kJ (=500kcal) energy deficit per day. Both groups had an equal number of 
lab visits during the 7 months. Before, and after 4 and 7 months, subjects performed a 12-min 
time trial (TT; 6+6min, 2min pause) and an incremental cycling test (ICT) to exhaustion and 
blood lipids were assessed. Results: Weight loss was significant and similar in both groups (-4.2 
vs -3.7kg; both p<0.05). During the first 4 months, distance covered in 12min improved more 
(p<0.05) with R+EN (1678 vs 1824m; p<0.001) than with EN alone (1638 vs 1698m; p<0.05), 
while after R+EN, breathlessness during the ICT was reduced. Blood lipids of the pooled group 
improved in those subjects with pathologic values before the study.  Despite reduced training 
compliance  during  the  unsupervised  period,  subjects  of  both  groups  maintained  the  benefits 
attained during the supervised period. Conclusion: R+EN improved TT-performance more than 
EN alone, despite similar weight loss, possibly due to reduced perception of breathlessness.
Keywords: Respiration, training, breathlessness, metabolism, sleep, quality of life
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INTRODUCTION
Paragraph Number 1  Obesity is  a widespread and growing problem worldwide.  The 
prevalence of overweight (body mass index  [BMI] ≥ 25 kg·m-2), including obesity (BMI  ≥ 30 
kg·m-2),  has increased by 40% from 1980 to 2004 in the United States (17).  In Europe,  the 
prevalence  of  overweight  and  obesity  varies,  depending  on  country,  from  28  to  79% 
(overweight) and from 5 to 35% (obesity; 39). Obesity is associated with multiple chronic health 
conditions,  including  coronary  heart  disease,  hypertension,  hyperlipidemia,  type  2  diabetes 
mellitus, depression, and obstructive sleep apnea, and is responsible for a large proportion of the 
health burden of Europe (38). In addition, health-related quality of life is impaired in overweight 
and obese subjects (34), independent of the prevalence of co-morbidities (28). Weight loss (5 - 
15% of the body weight) in obese individuals improves the risk factors associated with obesity 
(37).
Paragraph Number 2 Recommendations for the treatment of adults who are overweight 
or obese focus on energy balance with lifestyle modifications designed to reduce daily energy 
intake and increase physical activity. While reducing daily energy intake is the most effective 
method for decreasing weight and total fat mass rapidly (30), physical activity is crucial for long-
term  weight  management  (9,40)  and  may  play  a  role  in  preventing  obesity  or  preventing 
established obesity worsening (30). 
Paragraph Number 3 However, physical activity alone is of limited benefit in inducing 
weight loss (9). Reasons might be lack of time or motivation to engage in the high volume of 
activity required to lose a relevant amount of weight (40) or an increased level of breathlessness 
during physical exertion, rendering exercise too unpleasant. Babb et al. (6) showed, for example, 
that more than 37% of otherwise healthy young obese women suffer from an elevated perception 
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of breathlessness in response to moderate exercise. Because of this limitation, overweight and 
obese people may avoid intense daily activities and exercise – a vicious circle. 
Paragraph  Number  4  Respiratory  muscle  endurance  training  (RMET)  improves 
respiratory  muscle  and  exercise  endurance  (16,22,35)  and  reduces  the  perception  of 
breathlessness  and  respiratory  exertion  during  volitional  as  well  as  during  exercise-induced 
hyperpnea  in  healthy,  normal  weight  subjects  (35).  Thus,  it  is  an  interesting  concept  for 
overweight  and  obese  subjects  embarking  on  a  weight-reduction  program,  consisting  of  an 
exercise and nutrition counseling program (EN), to commence isolated RMET before beginning 
the EN. Furthermore, repeated volitional breathing tasks  such as RMET or didgeridoo-practice 
were shown to reduce snoring (14,26) and to improve the apnea/hypopnea index in subjects with 
mild  obstructive  sleep  apnea  (26).  Since  overweight  and  obese  subjects  have  an  increased 
prevalence of sleep apnea (1),  RMET in combination with EN may improve sleep quality and 
daytime sleepiness in this group of subjects. Therefore, the aim of the present study was to assess 
the effect of RMET, starting one month prior to EN and continuing throughout EN in overweight 
or  obese  subjects  perceiving  a  significant  amount  of  breathlessness  on  exertion,  on 
improvements in exercise performance, quality of life and daytime sleepiness, as well as weight 
reduction, changes in body fat, lipid profile and insulin sensitivity compared to EN alone. 
Paragraph  Number  5  We  hypothesized  that  a  reduction  in  the  perception  of 
breathlessness by RMET would make whole-body exercise more enjoyable, increase the level of 
spontaneous daily activities in addition to the EN program, and increase compliance with the 
program. This in turn would lead to a greater reduction in body weight and body fat content, and 
to  greater  improvements  in  exercise  performance,  quality  of  life,  sleep-quality,  daytime 
sleepiness and risk factors associated with coronary heart disease, compared to EN alone. 
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METHODS
Subjects 
Paragraph Number 6  Of 340 people that responded to advertisements, 113 visited the 
laboratory after detailed information by telephone. Of these, 50 subjects (36 female, 14 male) 
decided to participate and were enrolled in the study according to all but one inclusion criterion 
(see below).  Inclusion criteria were age between 18 and 50 years, BMI greater than 25 kg·m-2, 
normal lung function, absence of acute or chronic disease, and exercising for less than 3 h per 
week.  Exclusion  criteria  were  smoking,  taking  regular  medication,  cardiovascular  disease 
(electrocardiogram during exercise) including elevated resting blood pressure (> 130/85 mmHg), 
elevated fasting blood glucose (> 6 mmol·L-1) and insulin resistance (insulin < 6 mIU/l or > 27 
mIU/l), respiratory disease (VC and FEV1 < 90% predicted) including asthma, musculoskeletal 
disease, and depression. All exclusion criteria were assessed by a detailed medical history and, 
where  noted,  by  specific  measurements.  Subjects  gave  their  written  informed  consent  after 
detailed verbal and written information and after visiting the laboratory. The study was approved 
by the local ethics committee and conformed to the Declaration of Helsinki. 
Paragraph Number 7  A further inclusion criterion was scoring ≥ 5 for  breathlessness 
during the last stage of the  baseline  incremental cycling test (ICT).  17 of the enrolled subjects 
were excluded due to insufficient  perception of breathlessness during incremental  cycling.  A 
detailed  description  of  the  assessment  of  subjective  sensations  is  given  later.  Subjects  were 
randomly assigned and counterbalanced (considering age, height, weight and sex) to one of the 
two study groups: RMET+EN (R+EN) or EN.  Of the included subjects, two (1 R+EN, 1 EN) 
quit the study after the baseline-testing period, another five (3 R+EN, 2 EN) dropped out within 
the first (supervised) 4 months, and one (R+EN) within the following (unsupervised) 3 months. 
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Reasons were lack of time (4), change of job description (2), moving (1) and pregnancy (1). 
Paragraph Number 8 Finally, 15 subjects (12 female, 3 male) in the R+EN-group and 11 
subjects  (8 female,  3 male)  in the EN-group completed the first  4 months  of the study (age 
R+EN: 34 ± 8 y [mean ± SD], EN: 32 ± 9 y; height: 1.71 ± 0.07 and 1.71 ± 0.09 m; weight: 91.6 
± 15.3 and 93.3 ± 20.5 kg; systolic blood pressure: 116.8 ± 9.7 and 116.1 ± 11.5 mmHg; diastolic 
blood pressure: 73.1 ± 6.9 and 73.8 ± 6.3 mmHg). 
Protocol overview
Paragraph Number 9  The study included three different  periods (Fig.  1):  i)  1 month 
RMET or control, ii) 3 months supervised R+EN/EN, iii) 3 months unsupervised R+EN/EN. At 
baseline,  subjects  reported  to  the  laboratory  on  five  different  occasions  (Fig. 2;  5-day 
testing period), separated by at least 48 h, but within 2 weeks. This 5-day testing period was 
repeated after the 1-month RMET/control-period, after the 3-month supervised period and after 
the final 3-month unsupervised period. Tests were performed in the same order (see Fig. 2) and 
on the same time of day as at baseline. In addition, a reduced test set was carried out (Fig. 2; 2-
day testing period) one and two months into the supervised period. Subjects were not permitted 
to perform any physical exercise the day before the test or to ingest any caffeinated food or drink 
the day of the test. Sleep duration during the two nights before testing was required to be at least 
7 h and the last meal had to be eaten at least 2 h prior to testing. During the entire study period, 
subjects  were requested to maintain their  personal physical  training at a level comparable to 
before the study and to complete a logbook where all trainings, including RMET, were recorded 
with time, duration and intensity. Also, during each training session, subjects were requested to 
record their heart rate (Polar S610i, Polar Elector, Kempele, Finland). Logbook and heart rate 
readouts were regularly checked by the experimenter. During 4 days immediately prior to every 
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5-day  testing  period,  subjects  were  requested  to  record  their  dietary  intake  and  subjective 
variables, to wear an accelerometer and to assess sleep quality for two nights at home (for details 
see later).
Figure 1
Figure 2
Details of the different study periods
1-month RMET/control-period
Paragraph Number 10 During the first month, the R+EN-group performed 20 sessions 
of normocapnic hyperpnea which were carried out mostly at home with every 5th training session 
supervised in the laboratory (for details see below). The control group performed no specific 
training  but  reported  regularly  to  the  laboratory  to  assess  lung  function,  respiratory  muscle 
strength, skinfold thickness and circumferences. Control subjects did not know that the other 
group performed RMET during this period and believed that the groups differed with respect to 
the EN-program. They were informed that these initial  measurements were essential  baseline 
measurements before the start of the EN program. Similarly, the RMET-group did not know the 
details of the program of the 'other' group. Twice during this first month, all subjects visited the 
fitness center to familiarize themselves with the endurance and strength-training equipment to be 
used in the following six months of EN. 
3-month-supervised R+EN/EN-period
Paragraph Number 11  During the following 12  weeks, R+EN-subjects performed two 
RMET-sessions per week. All subjects adhered to a prescribed EN (for details see below) with 
experimenter-contact twice per month when they reported to the laboratory. During these visits, 
R+EN-subjects  performed an RMET or an interval  cycling  training,  in alternating order  (for 
details  see  below),  and  EN-subjects  performed  interval  cycling  trainings.  These  supervised 
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trainings served to control correct performance but also to discuss adherence to and problems 
with the program, individual achievements and to check training logbooks. 
3-month-unsupervised R+EN/EN-period
Paragraph Number 12 For the next 12 weeks, subjects were asked to continue with their 
respective program, but without arranged contact to the experimenters or testing. Subjects were 
however free to contact the experimenters at any time with questions or if advice was needed.
Respiratory muscle endurance training (RMET)
Paragraph Number 13  RMET in the form of normocapnic hyperpnea was performed 
with  the  SpiroTiger device  (idiag,  Fehraltdorf,  Switzerland),  which  records  each  training 
session.  This device uses partial  rebreathing  and ensures normocapnia.  Tidal  volume (VT)  is 
controlled by feedback, and breathing frequency (fR) is paced with a duty cycle of 0.5. Target 
minute ventilation ( EV ) was initially set at 50% maximal voluntary ventilation (MVV) and was 
increased throughout the training period such that the subjects were exhausted at the end of each 
30-min  training  session.  For  supervised  trainings  in  the  laboratory,  the  training  device  was 
connected to the metabolic cart to control for the training technique and to ensure normocapnia 
was maintained. 
Exercise and nutrition counseling program
Paragraph Number 14 Subjects in the present study were requested to exercise on five 
days  per week for 20 – 45 min.  The weekly exercise  program consisted of three endurance 
training sessions alternating with two strength training sessions, designed to take place in the 
fitness center. Subjects were allowed to train more than prescribed if desired, because the study 
was  designed  to  imitate  reality  where  no  upper  exercise  limit  exists.  Therefore,  rather  than 
restricting  subjects  to  the  prescribed  exercise  program  only,  the  volume  of  prescribed  and 
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unprescribed exercise was carefully supervised to assess whether RMET and possible resulting 
reduced  perception  of  breathlessness  would  motivate  subjects  to  exercise  more.  During  the 
training sessions, heart rate was recorded not only to assess training compliance but also to give 
the subject feedback on training intensity.  For all sessions,  training variables and times were 
recorded in a logbook.
Paragraph Number 15 The three endurance training sessions consisted of two constant-
load sessions and one interval training with durations starting at 20 min (1st-4th week), increasing 
to 30 min (5th-8th week) and then to 45 min (from 9th week) for the remainder of the EN. During 
constant-load training, subjects cycled, walked/ran or rowed at a heart rate corresponding to 45% 
of peak oxygen consumption ( 2peakOV ) (1st-6th week) which was then increased to 50% 2peakOV  
(7th-15th week) and finally to 55% 2peakOV  (from 16th week) for the remainder of the EN. Interval 
training  was  performed  on  a  cycle  ergometer,  where  resistance  alternated  between  a  load 
corresponding to 45% 2peakOV  (80 s, 1st week) and 80% 2peakOV  (40 s, 1st week). Durations of the 
two loads were then changed to 70 s / 50 s (7th-15th week) and 60 s /  60 s (from 16th week). 
Durations of the entire interval training sessions changed as noted above. 
Paragraph Number 16  Strength training consisted of leg curls, leg presses, abdominal 
crunches,  torso  rotations,  lower  back  extensions,  chest  presses,  lat  pull  downs and shoulder 
presses. Each exercise consisted of a concentric phase lasting 4 s, stop at reversal for 2 s and an 
eccentric phase of 4 s. The load was chosen such that the specific muscle group was exhausted 
within 60 – 90 s. Once 90 s was reached, the load was increased. Subjects then performed the 
exercise with this load until they reached 90 s again, and so on. Only one set of each exercise 
was performed per training session. 
Paragraph Number 17 The energy of the prescribed diet consisted of 20–30% fat, 50–
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60% carbohydrates and 10–20% proteins. Diet counseling focused on the use of polyunsaturated 
fat, whole-grain carbohydrates, fresh fruit and vegetables. The required energy deficit had to be 
at least 2.1 kJ (= 500 kcal). Energy intake was calculated relative to the daily energy expenditure 
(for details see below).
Material and measurements
Body weight and body fat
Paragraph Number 18 For body weight and BMI, averages of four measurements (5-day 
testing period) and of two measurements (2-day testing period) were calculated and compared. 
Skinfold  thicknesses  were  measured  using a  skinfold  caliper  (Siber  Hegner,  Zurich, 
Switzerland).  Each  skinfold  was  measured  at  least  three  times,  and  the  mean  of  three 
reproducible  values  (less  than  5% variation)  was  calculated.  To  calculate  percent  body  fat 
according to the Peterson formula (25), the following sites were assessed: triceps, subscapular, 
suprailiac and mid thigh. Waist circumference was measured at the end of gentle expiration. In 
addition, hip-circumference was measured. Body fat content was measured during the first and 
the last 5-day testing period by dual-energy X-ray absorptiometry (DEXA; QDR 4500 Hologic, 
Bedford, USA).
Resting and daily energy expenditure 
Paragraph Number 19  Resting energy  expenditure was assessed within the first 5-day 
testing period by indirect calorimetry. Subjects reported to the laboratory after an overnight fast 
and reclined in a sun lounger wearing a nose clip and mouthpiece. Gas exchange was recorded 
continuously (Oxycon mobile, Jaeger, Höchberg, Germany) for at least 10 min or until achieving 
a respiratory steady state when subjects were sitting in a sun lounger. To calculate daily energy 
expenditure, resting energy expenditure (2 min of steady state data) was multiplied by subjective 
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physical activity level, assessed by a questionnaire (8). 
Paragraph Number 20 At each test session, subjects completed an activity questionnaire 
(7) to retrospectively assess their daily energy expenditure over the duration of the past week. In 
addition, subjects wore an accelerometer (Actigraph AM 7164, MTI Manufacturing Technology, 
Fort  Walten  Beach,  FL)  for  four  consecutive  days  (three  weekdays,  one  weekend  day) 
immediately  prior  to  each  5-day  test  session  to  estimate  daily  energy  expenditure  more 
accurately. During the same four days, subjects recorded all details of their food consumption in 
a logbook. For analysis  of the accelerometer data, the following activity levels were chosen: 
sedentary: 1-99 counts*min-1, light: 100-1951 counts*min-1, moderate: 1952-5724 counts*min-1, 
heavy: 5725-9498 counts*min-1, very heavy: > 9498 counts*min-1 (13).
Incremental cycling test (ICT)
Paragraph Number 21 Subjects sat on an electromagnetically braked bicycle ergometer 
(Ergometrics 900, Ergoline, Bitz, Germany) with a nose clip in place, and were connected to the 
metabolic cart via a mouthpiece to assess ventilation and gas exchange (Oxycon mobile, Jaeger, 
Höchberg, Germany). Gases were measured by electrochemical O2- and CO2-sensors that use the 
principle of heat conductance. After 5 min of rest, subjects started cycling for 2 min at 60 W 
(women) or 80 W (men). Subsequently, the workload was increased by 20 W every 2 min until 
exhaustion. The subjects chose their preferred pedaling frequency (between 60 and 100 rpm) 
during  the  first  two steps  of  the  ICT and this  frequency was  then  held  constant  during  the 
remainder of this test and during subsequent tests. The test finished when subjects stopped or 
when the cadence could no longer be sustained within ± 3 rpm of the target. Subjects were not 
encouraged  by  the  experimenter.  Heart  rate  was  measured  continuously  using  a  12-lead 
electrocardiogram (Oxycon mobile,  Jaeger,  Höchberg,  Germany).  At the end of every 2-min 
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stage, subjects were asked to rate their breathlessness, respiratory exertion, and leg exertion on a 
visual analogue scale (see below). In addition, at the end of each stage, 20 µl of arterialized 
venous blood were drawn from an earlobe to assess blood lactate concentration enzymatically 
(Biosen 5040-lactate analyzer; EKS Industrie Elektronik, Magdeburg, Germany).
Paragraph Number 22  ICT-data was analyzed at the point of exhaustion: Averages of 
ventilation, gas exchange and heart rate were calculated over the last 30 s of each test while for 
blood lactate concentration and rating of sensations the values at the point of exhaustion were 
taken. Maximal workload ( maxW ) was extrapolated proportionally according to time spent at the 
final workload, and 2peakOV  was defined as the highest 15 s-average of oxygen consumption (
€ 
Ý  V  O 2
). For comparison of physiological variables at submaximal exercise,  6-min averages over the 
last three iso-stages (iso = at the same time after the start of a test, independent of the total test 
duration) were calculated.
Walk/run time trial (TT) 
Paragraph Number 23  A 12-min  walk/run time trial  (TT) with 2 min  recovery after 
6 min  was  chosen  to  evaluate  endurance  performance.  This  design  was  chosen  because  i) 
walking and running better reflect the daily activities of overweight and obese subjects than other 
forms  of  exercise,  e.g.  cycling,  ii)  the  reliability  of  a  TT  is  higher  compared  to  time-to-
exhaustion tests (21), and iii) the 6-min walking distance is a well-established clinical test (3). To 
increase  the  endurance  component,  subjects  performed  two  6-min  walk/runs  with  a  2-min 
recovery period in between. However, subjects were asked to cover the largest distance possible 
within the first 6 min without thinking of their performance in the second test. In the second test, 
subjects were requested to do as good as possible in face of having passed an exhaustive first 
test. For both tests, subjects received no encouragement from the experimenter. However each 
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minute  the  remaining  number  of  minutes  was  shouted.  Ventilation  and  gas  exchange  were 
recorded continuously  using a  face mask (Oxycon mobile,  Jaeger,  Höchberg,  Germany)  and 
heart rate was recorded every 5 s (Polar S610i, Polar Electro, Kempele, Finland). The test was 
performed in a corridor with a marked distance of 75 m between which subjects walked/ran back 
and forth. Every 150 m,  subjects  were asked to rate their  level of breathlessness,  respiratory 
exertion and leg exertion between 0 and 10 (see below) by holding up the fingers on both hands. 
Before the first run as well as at the end of both runs, a 20-µL sample of arterialized capillary 
blood was drawn from an earlobe for blood lactate analysis (Biosen 5040-lactate analyzer; EKS 
Industrie  Elektronik,  Magdeburg,  Germany).  TT-ventilation,  gas  exchange,  heart  rate, and 
sensations were averaged over the first and second 6-min run separately and over the entire 12-
min run. For blood lactate concentration the values at the end of the second run were taken. 
Assessment of subjective sensations 
Paragraph  Number  24  Breathlessness,  respiratory  exertion  and  leg  exertion  during 
exercise  (except  TT)  were assessed by means  of  a  visual  analogue  scale  consisting of  three 
horizontal lines split post-hoc into values between 0 and 10. They were labeled with the three 
qualities and ranged from “none” on the left-hand side to “maximal” on the right-hand side. 
Subjects were interviewed extensively prior to the test session regarding their experience and 
understanding  of  the  different  respiratory  sensations.  Subsequently,  they  discussed  with  the 
experimenter which sensations meant breathlessness (Atemnot, i.e. the sensation of “not getting 
enough air”) and which meant respiratory exertion (Atmungsanstrengung, i.e. “how difficult it is 
to breathe”), respectively.  This ensured that subjects could distinguish between  breathlessness 
and respiratory exertion (15,20). The definitions were read to the subjects before each exercise 
test, and the following calibration terms were used as previously discussed with the subjects: 
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“none” was defined as perceiving no breathlessness, respiratory exertion or leg exertion, similar 
to the sensation when sitting on a chair at rest; “maximal” was defined as the intensity at which 
the exercise would have to be stopped immediately due to this particular sensation. 
Quality of life
Paragraph  Number  25 Subjects  completed  a  German  translation  of  the  SF-36 
questionnaire (10,29) to evaluate physical and mental aspects of their quality of life. In order to 
create a reference for data of the SF-36 questionnaire, norm values for the demographics of our 
study population were calculated from norm values of a German population (10).
Paragraph Number 26  In addition, subjects scored their level (0-10) of breathlessness, 
perceived well-being, tiredness and hunger during 4 consecutive days  (1 weekend day and 3 
week days; same days as dietary protocol) when prompted by the monitor at 10 am, 3 pm and 
8 pm  by  means  of  a  wrist-worn  monitor  (Actiwatch  Score,  Cambridge  Neurotechnology, 
Cambridge, UK). For the different subjective sensations that were each assessed at 10 am, 3 pm 
and 8 pm over 4 days, the average over the four consecutive days of each 5-day testing period 
was calculated separately.
Venous blood analysis
Paragraph Number 27  The subjects reported to the laboratory after an overnight fast. 
30 ml of venous blood were drawn from a cubital vein to assess fasting serum concentrations of 
insulin,  glucose,  total  cholesterol,  low-density  lipoprotein  (LDL)  cholesterol,  high-density 
lipoprotein  (HDL)  cholesterol,  and  triglycerides.  Blood was  drawn into  a  lithium-heparinate 
vacutainer for lipid analysis  and into a sodium-fluoride/oxalate vacutainer for fasting glucose 
analysis. The tubes were centrifuged and blood serum was separated from blood cells. The serum 
was  analyzed  at  the  Institute  of  Clinical  Chemistry  of  the  Zurich  University  Hospital 
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(Switzerland) using routine techniques.
Sleep 
Paragraph Number 28  During two consecutive  nights  within a  5-day testing period, 
subjects  wore,  at  home,  a  pocket  sized  digital  recorder  (Compass  F10,  Medcare  Flaga, 
Reykjavik, Iceland) designed to diagnose sleep-disordered breathing and estimate sleep quality 
from records of nasal  pressure (flow),  activity,  position and oxygen saturation.  Furthermore, 
subjects  completed the Epworth Sleepiness Scale to evaluate their daytime sleepiness (18). For 
sleep analysis, the second of the two nights was analyzed. Apnea was defined as cessation of 
airflow for ≥ 10 s with decrements in blood oxygen saturation of ≥ 3%. Hypopnea was defined as 
a reduced airflow for ≥ 10 s with decrements of blood oxygen saturation of ≥ 3% (2). 
Lung function, respiratory muscle strength and airway resistance (Raw)
Paragraph Number  29  Resting  lung  function  as  well  as  maximal  inspiratory  mouth 
pressure  (PImax)  and  maximal  expiratory  mouth  pressure  (PEmax) were  measured  in  standing 
position according to standard procedures (4,5). Vital capacity (VC), forced expiratory volume in 
one second (FEV1), peak expiratory flow (PEF), and MVV were  determined by means of an 
ergospirometric device (Oxycon mobile, Jaeger, Höchberg, Germany) using a calibrated turbine 
for volume measurement.  PImax from residual volume and PEmax from total lung capacity were 
assessed over 1 s with a small  air leak in the measurement  device to prevent glottis  closure 
(MicroMPM, Micro Medical,  Rochester,  UK).  A nose  clip  was  used  for  all  efforts.  Airway 
resistance  (Raw)  was  measured  in  sitting  position  using  the  Master  Screen  Diffusion  Device 
(Jaeger, Höchberg, Germany) according to standard procedures (23). Raw was assessed by using 
the  interrupter  technique and  was  determined  by  averaging  the  last  five  of  at  least  ten 
reproducible values. Raw was assessed before and after the respiratory endurance test (RET) at 
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isotime to assess the change in Raw during heavy breathing. For lung function, respiratory muscle 
strength and Raw, % predicted values were calculated. Due to technical problems some subjects 
had to be excluded in the analysis of respiratory muscle strength and Raw (numbers are given in 
results where appropriate).
Respiratory endurance test (RET)
Paragraph  Number  30  At  baseline,  subjects  (in  sitting  position)  were  requested  to 
breathe to exhaustion at a given target ventilation using a partial rebreathing device (SpiroTiger, 
idiag, Fehraltdorf, Switzerland) to ensure normocapnia. During the three familiarization sessions 
within the first 5-day testing period, a level of ventilation was chosen by the investigators that 
ensured the subjects could continue for a minimum of 8 min but a maximum of 15 min. This 
resulted in an average target EV  of 67 ± 10% MVV for the R+EN-group and 66 ± 4% MVV for 
the EN-group. Subjects were required to maintain this pre-selected EV  while holding VT and fR 
constant. If necessary, the test administrator asked the subjects to correct their VT and fR that was 
supervised on the metabolic  cart,  ensuring normocapnia was maintained.  The test  was either 
stopped by the subjects due to exhaustion or by the test administrator when subjects were no 
longer able to sustain target VT and fR. In the subsequent RETs, subjects breathed with identical 
target EV  and breathing pattern for the same duration as during the RET at baseline. After a 4-
min break where Raw was measured, they continued breathing until exhaustion at the same level 
of ventilation. These tests were stopped according to the criteria above or after a maximum of 
60 min  breathing.  Ventilation  and  end-tidal  CO2  partial  pressure  (PETCO2)  were  recorded 
continuously  (Oxycon mobile, Jaeger, Höchberg, Germany) and heart rate was recorded every 
5 s (Polar S610i, Polar Electro, Kempele, Finland). Every 2 min, subjects rated their perception 
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of breathlessness and respiratory exertion on a  visual analogue scale,  and a 20 µL- sample of 
arterialized capillary blood was drawn from an earlobe for blood lactate analysis (Biosen 5040-
lactate analyzer;  EKS Industrie Elektronik,  Magdeburg, Germany). Ventilation,  PETCO2,  heart 
rate,  blood lactate  concentration, and  sensations  were averaged over  the test-duration  of  the 
shortest test, i.e. during identical durations. 
Data analysis 
Paragraph Number 31 The number of subjects was different between the supervised and 
the unsupervised period. To have the largest possible number of subjects available for analysis, 
within-group  comparisons  from  before  to  after  the  supervised  period  (n=26)  and  the 
unsupervised period (n=25) were performed separately by using student’s paired t-test. Between-
group comparisons of within group-changes from before to after the supervised/unsupervised-
period  were  performed  using  unpaired  t-tests.  The  Pearson product-moment  correlation  was 
applied  for  assessing  possible  relations  between  changes  from  before  to  after  the 
supervised program within groups. Analyses were performed using a computer software package 
(SPSS  11  for  Mac  OS  X,  Chicago,  Illinois,  USA). Statistical  significance  was  accepted  at 
p < 0.05. We also show statistical trends (i.e. p < 0.1) where appropriate.
RESULTS
Training compliance
Paragraph  Number  32  During  the  first  month  of  RMET,  training-compliance  with 
RMET was 97 ± 6% while it decreased to 63 ± 18% during the supervised period and further to 
35 ± 34% during the unsupervised period. Physical  training compliance was similar between 
groups  both  during  the  supervised  period  (R+EN-group:  81 ± 15%;  EN-group:  89  ±  8%; 
p = 0.161)  and  the  unsupervised  period  (R+EN-group:  51  ±  35%;  EN-group:  63  ±  18%; 
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p = 0.377). In both groups, training compliance with physical  training significantly decreased 
during the unsupervised period compared to the supervised period (both: p < 0.05). During the 
supervised period, R+EN-subjects performed an additional 10 ± 8 trainings, meaning that they 
undertook  extra  trainings  (which  was  allowed  in  addition to  the  program).  EN-subjects 
completed an additional 21 ± 23 trainings (p = 0.104). During the unsupervised period, R+EN-
subjects performed 11 ± 18 extra trainings and the EN-group an additional 13 ± 16 (p = 0.813).  
Body weight, body fat content and circumferences 
Paragraph  Number  33  Baseline  anthropometric  data  were  similar  between  the  two 
groups (all p > 0.05; Table 1, Fig. 3). After the first 4 months of supervised training, body weight 
decreased in both groups by the same magnitude (statistical power 98%; Fig. 3) while body fat 
content  decreased  significantly  in  the  R+EN-group and tended to  decrease  in  the  EN-group 
(Table 1). During the following 3-month-unsupervised training period, body weight tended to 
decrease further with R+EN while it decreased significantly with EN. Body weight and % body 
fat  reduction  did  not  correlate  with  changes  in  self-reported  energy expenditure,  changes  in 
energy intake or with training  compliance in either  group. Waist  circumference significantly 
decreased with R+EN in the supervised period,  while EN had no effect  (Table 1). When all 
subjects were considered as one pooled group (R+EN + EN), waist circumference was reduced 
significantly after the supervised period (before: 1.02 ± 0.15 m, after: 0.98 ± 0.14 m, p < 0.01) 
while no further change was observed after the unsupervised period (before: 0.97 ± 0.14 m, after: 
0.96 ± 0.15 m, p = 0.170). 
Figure 3
Table 1
Energy intake and expenditure
Paragraph Number 34 After the 4-month supervised period, R+EN-subjects reported a 
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larger energy deficit (-1.1 kJ·day-1) than prescribed and the same tendency was observed for EN-
subjects (-1.8 kJ·day-1; Table 1). For both groups, fat intake (prescription: 20–30%) stayed at the 
upper  limit  during  this  period  (R+EN:  26–43%,  EN:  26–40%)  and  carbohydrate  intake 
(prescription:  50–60%)  was  too  low  (R+EN:  37–58%,  EN:  42–61%).  By  the  end  of  the 
unsupervised period, R+EN subjects reported a calorie intake corresponding to the prescription 
while that of EN-subjects was significantly lower compared to prescription. The level of self-
reported daily energy expenditure increased after the supervised R+EN-period, while it remained 
the same after EN. The increased energy expenditure during the supervised period compared to 
baseline is also reflected in the increased duration spent at higher activity (≥ moderate activity) 
in R+EN (Table 1).
Incremental cycling test (ICT)
Paragraph Number 35 maxW  (Fig. 3) and 2peakOV ·kg-1 significantly increased with R+EN 
during  the  4-month  supervised  period  (R+EN:  before:  29  ±  6  mL·min-1·kg-1,  after:  32  ±  6 
mL·min-1·kg-1, p < 0.01; EN: before: 28 ± 5 mL·min-1·kg-1, after: 29 ± 6 mL·min-1·kg-1, p = 0.235; 
between groups: p = 0.461). At exhaustion, breathlessness was significantly reduced after R+EN 
compared to EN alone (R+EN: before: 9.4 ± 1.0, after: 6.4 ± 4.1 points, p < 0.01; EN: before: 8.1 
± 1.7, after: 7.8 ± 1.9 points, p = 0.709; between groups: p < 0.05). Both programs significantly 
and similarly reduced heart rate (R+EN: before: 180 ± 14 beats· min-1, after: 174 ± 10 beats· 
min-1, p < 0.01; EN: before: 178 ± 8 beats· min-1, after: 168 ± 14 beats· min-1, p < 0.01; between 
groups:  p  =  0.190).  Maximal  blood  lactate  concentration  remained  unchanged  after  R+EN 
(before: 9.3 ± 1.5 mmol·L-1, after: 9.3 ± 2.2 mmol·L-1, p = 0.884) and was reduced after EN 
(before: 8.1 ± 3.0 mmol·L-1, after: 6.6 ± 2.8 mmol·L-1, p < 0.05; between group: p < 0.05). At 
submaximal levels (Table 2) ventilation and perception of breathlessness were reduced during 
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the last 6 min of the test. After both R+EN and EN, submaximal heart rate and blood lactate 
concentration  were  significantly  lower.  No  further  changes  were  observed  in  the  following 
unsupervised 3-month period. 
Table 2
Paragraph  Number  36  In  the  R+EN-group,  reduction  in  breathlessness  during 
submaximal exercise tended to correlate with changes in maxW  (r2 = 0.23, p = 0.072) and 2peakOV  
(r2 = 0.23, p = 0.067), but did not correlate with changes in anthropometric data and self-reported 
energy expenditure. Improvements in 2peakOV ·kg-1 correlated with training compliance (r2 = 0.42, 
p < 0.05). For the pooled group, changes in daily energy expenditure significantly correlated 
with changes in maxW  (r2 = 0.16, p < 0.05).
Time trial (TT)
Paragraph Number 37 Baseline 12-min distance did not differ significantly between the 
two groups (R+EN: 1678 ± 269 m, EN: 1638 ± 256 m, p = 0.704). After the 4-month supervised 
period, TT-performance improved significantly more in the R+EN-group (statistical power for 
improvement  100%)  than  in  the  EN-group  (Fig.  3,  Table  2),  while  EV ,  perception  of 
breathlessness, respiratory exertion and leg exertion, heart rate, and blood lactate concentration 
remained unchanged. During the following 3-month unsupervised period,  no further  changes 
were observed (Table 2). 
Paragraph Number 38 In the R+EN-group, changes in the perception of breathlessness 
during  the  ICT  tended  to  correlate  with  improvement  in  TT-performance  (12-min  distance: 
r2 = 0.22,  p = 0.074;  second 6-min  run:  r2 = 0.20,  p = 0.095) after  the  first  4  months.  This 
correlation  was significant  when analyzed  for  the pooled group (12-min  distance:  r2 = 0.24, 
p < 0.05; first 6-min run:  r2 = 0.30, p < 0.01). TT-performance-changes did not correlate with 
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changes in anthropometric data or the change in self-reported daily energy expenditure. 
Quality of life
Paragraph Number 39 Details of subjective rating of quality of life and daily perception 
of subjective sensations are given in Table 3. Before the start of the intervention-period, scores 
of the mental  component  summary were below or at  the 25th percentile  for both groups and 
remained the same during the entire study period. The average score of the physical component 
summary lay between 25th and 50th percentile in both groups before the start of the intervention 
period and significantly and similarly increased during the supervised 4-month period (pooled 
group:  before: 49 ± 6, after: 54 ± 5, p < 0.001)  and then remained unchanged. Perception of 
general health improved significantly after R+EN but not after EN (R+EN: before: 63 ± 12, after: 
76 ± 12, p < 0.05; EN: before: 70 ± 14, after: 70 ± 14, p = 0.982; between within-group-changes: 
p < 0.05).
Table 3
Paragraph  Number  40  Training  compliance,  body  weight  and  %  body  fat  did  not 
correlate  with  improvement  in  the  perception  of  physical  well-being  in  either  group.  In  the 
R+EN-group, reduction in breathlessness during submaximal exercise tended to correlate with 
improvements in the perception of general  health  (r2 = 0.21,  p = 0.085), while they did not 
correlate  with  changes  in  the  physical  component  summary.  For  the  pooled  group,  the 
improvements in maxW  and the reduction in breathlessness correlated with the change in physical 
component summary ( maxW : r2 = 0.21, p < 0.05; breathlessness: r2 = 0.16, p < 0.05).
Metabolic blood parameters
Paragraph Number 41 Values of the different metabolic blood parameters are given in 
Table 4. Changes did not correlate  with absolute changes in body weight, BMI, % body fat, 
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dietary intake, self-reported energy expenditure nor with the change in fitness level ( maxW , 2peakOV /
kg, 12-min distances) of the pooled group. 
Table 4
Paragraph Number 42 However, if only subjects with  pathologic values at the start of 
the study were included in the analysis of the pooled group, blood lipids tended to improve after 
the  supervised  period  (total  serum  cholesterol:  before:  5.8  ±  0.8  mmol·L-1,  after:  5.4  ±  1.2 
mmol·L-1,  p  = 0.080, n  = 10;  HDL-cholesterol:  before:  0.9  ± 0.0  mmol·L-1,  after:  1.0  ± 0.1 
mmol·L-1,  p  =  0.062,  n  =  3;  LDL-cholesterol:  before:  3.7  ±  0.7  mmol·L-1,  after:  3.4  ±  1.2 
mmol·L-1, p < 0.050, n = 11; total serum triglycerides: before: 2.6 ± 0.3 mmol·L-1, after 1.9 ± 0.9 
mmol·L-1, p = 0.164; n = 3). Insulin levels did not change (insulin: before: 5.0 ± 1.6 mLU·l-1, 
after: 4.8 ± 2.1 mLU·l-1, p = 0.853, n = 5). In this pooled group, correlations were performed only 
for variables with a large enough number of subjects. The reduction in total serum cholesterol 
tended to correlate with the improved 12-min TT-performance (r2 = 0.38, p = 0.056), but changes 
in blood lipids did not correlate with changes in body weight.
Sleep
Paragraph Number 43 Although apnea/hypopnea index remained unchanged during the 
supervised period in both groups (R+EN: before:  2.6 ± 4.1, after:  3.1 ± 3.2, p = 0.661; EN: 
before: 3.3 ± 5.3, after: 3.4 ± 4.6, p = 0.947; between within-group-changes: p = 0.793), R+EN 
significantly decreased daytime sleepiness while EN alone had no such effect (Table 3; note: 
before the intervention period, five subjects of the R+EN-group and one subject of the EN-group 
reported excessive daytime sleepiness, i.e. Epworth Sleepiness Scale-score > 10). In both groups 
changes in daytime sleepiness did not correlate with changes in body weight, BMI, % body fat, 
self-reported daily energy expenditure  or physical  performance (all  p > 0.05). For the pooled 
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group, the change in 2peakOV /kg correlated significantly with the change in daytime sleepiness (r2 
= 0.30, p < 0.01).
Lung function and maximal respiratory muscle strength
Paragraph Number 44  In  Table  5  lung function  and respiratory muscle  strength are 
shown. Before the start of the intervention period, Raw was higher than predicted in both groups 
(both groups: p < 0.01). After the 4-month supervised program, Raw was significantly lower with 
R+EN but did not change significantly with EN alone.
Table 5
Respiratory endurance test (RET)
Paragraph Number  45  R+EN Breathing  duration  increased  significantly  after  the  4-
month supervised period while EN alone had no significant effect. However, breathing duration 
decreased slightly but significantly after  the 3-month unsupervised training period (Table 5). 
Similarly,  the  perception  of  breathlessness,  respiratory  exertion,  as  well  as  blood  lactate 
concentration were reduced after R+EN only.
DISCUSSION
Paragraph Number 46 In the present study, we found that overweight and obese subjects 
with a significant perception of breathlessness during exercise who performed RMET one month 
prior  to  and during  a  3-month  supervised  EN program improved  their  running performance 
significantly more than a group that performed EN only despite similar weight loss and reduction 
in % body fat. In addition, maximal cycling performance improved after R+EN but not after EN. 
This  difference  between  groups  may  result  from  the  significantly  reduced  perception  of 
breathlessness or underlying changes, e.g. increased respiratory muscle endurance, in the group 
that performed RMET. The following 3-month-unsupervised training period did not yield further 
improvements but neither did performance deteriorate. This is possibly a result of the reduced 
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training compliance in both groups during the unsupervised training phase. The overall benefit of 
both training regimes is reflected in improved quality of life, particularly an improved physical 
component. For the subgroup of subjects that started out with a pathological blood lipid profile, 
an improvement was seen during the training period. In summary, although the effect of the two 
programs on body weight  loss,  amount  of energy expenditure,  quality  of life  and long-term 
compliance with the program was similar between groups, the addition of RMET resulted in a 
decrease in breathlessness and a greater improvement in performance.
Weight loss
Paragraph Number 47  For both groups of subjects, the weight loss resulting from the 
daily energy deficit of 2.1 kJ was expected to be 0.5 kg·wk-1 which would, in accordance with 
Wadden et al. (36), result in a total loss of 12 kg over the 6 months. Given the self-reported 
larger energy deficit in both groups, weight loss was expected to be greater. However, only four 
R+EN-subjects (27%) and two EN-subjects (18%) lost ≥6 kg during the supervised period and 
only two R+EN- and no EN-subjects lost ≥6 kg during the unsupervised period. Although more 
R+EN-subjects reached the goal, the groups as a whole did not differ in the amount of body 
weight or body fat lost over time. In fact,  the numbers are in the same range as reported in 
systematic reviews by Shaw et al. (30) with an average weight loss for a 3-month period of 3.4 - 
17.7 kg, and Curioni et al. (11), where the average weight loss for a 3-month period was around 
4.2 kg.
Exercise performance
Paragraph  Number  48  After  the  supervised  intervention  period,  TT-performance 
improved more with R+EN than with EN alone. In this period, maxW  improved only with R+EN. 
Interestingly,  clinically  relevant  improvements  of  >70 m  within  6 min,  a  number  given  for 
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respiratory patients (3), were only achieved in the second of the two 6 min runs (R+EN: +96 ± 
45  m,  EN:  +73  ±  44  m).  This  could  either  result  from the  fact  that  subjects  were  not  as 
deconditioned as cardio-respiratory patients (3), resulting in smaller scope for improvement, that 
the present exercise program mainly improved the longer duration endurance component, or that 
subjects did not perform to their maximum in the first of the two runs after the first training 
period. Although it is theoretically possible that subjects paced themselves for 12 min rather than 
6 min, it seems unlikely to us. We believe that subjects performed at their maximum during the 
first 6-min run, as we emphasized prior to each test explaining that subjects had to cover the 
largest distance possible within the first 6 min. During the unsupervised period, subjects trained 
less and thus it is not surprising that performance did not continue to improve but remained 
constant during this period of time. 
Paragraph Number 49  Interestingly physical  training did not  affect  maximal  cycling 
performance of the EN-group during the supervised period. It is likely that the training intensity 
designed to optimize fat-burning was too low to improve maximal performance. 
Paragraph Number 50 Given the similar amount of physical training between the R+EN 
and the EN-group during the 3-month supervised period, the greater improvement in exercise 
performance in the R+EN-group is likely, at least in part, to result from increased respiratory 
muscle  endurance  (seen  in  improved  RET-duration  and  MVV)  associated  with  reduced 
breathlessness. In addition, the reduction in Raw and FEV1, possibly reflecting increased airway 
patency, may have reduced resistive respiratory muscle work, reflected in reduced perception of 
respiratory  exertion  during  the  RET.  This  could  have  helped  to  reduce  the  development  of 
respiratory  muscle  fatigue  in  addition  to  improving  the  endurance  of  muscle  fibers  due  to 
intramuscular adaptations in respiratory muscles. In fact, respiratory muscle fatigue is thought to 
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impair exercise performance by a so-called metaboreflex (31) impairing leg muscle perfusion, 
thereby enhancing leg muscle fatigue and compromising performance. The significant reduction 
in blood lactate accumulation during isolated respiratory muscle work after R+EN suggests this 
mechanism  might  indeed  have  contributed  to  improved  exercise  performance  since  the 
concentration  of  lactic  acid  in  respiratory  muscles  was  shown to  be  one  factor  causing  the 
metaboreflex (27). 
Quality of life
Paragraph Number 51  From a subjective perspective,  the most important  question is 
whether improvements in running and cycling performance translate into improved quality of 
life.  Indeed,  perception  of  general  health  improved  after  R+EN  to  a  similar  degree  as 
breathlessness during respiratory and physical exertion. This might indicate that breathlessness 
was also reduced during daily living, improving subjects' perception of general health, supported 
by a trend for a correlation between the two. However, the overall physical component of quality 
of life improved to a similar degree in both groups. In the pooled group, in fact, the change in 
breathlessness not only significantly correlated with the change in TT- and ICT-performance but 
also breathlessness and ICT-performance correlated with the physical component of quality of 
life, hinting at a possible cause-effect relationship. This is also suggested by Tompkins et al. 
(33), who found improvements in TT-performance to correlate with improved perception of the 
physical component of quality of life.
Blood lipids
Paragraph  Number  52  Changes  in  blood  lipid  profile  resulting  from  the  present 
intervention were smaller than those reported by Shaw et al. (30) in their review (cholesterol: 
-0.15 to -1.4 mmol·L-1; triglycerides: -0.69 to +0.03 mmol·L-1; HDL: -0.1 to +0.1 mmol·L-1) if all 
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subjects were considered. However, when only subjects with pathologic values at baseline were 
included, improvements in blood lipid profile after the supervised period were in a similar range 
(pooled group: cholesterol: -0.34 ± 0.54 mmol·L-1; triglycerides: -0.73 ± 0.59 mmol·L-1; HDL: 
+0.08 ± 0.04 mmol·L-1). Blood lipid profile might have been positively affected by a change in 
visceral  fat  content,  an  assumption  that  is  supported  by  the  significant  reduction  in  waist 
circumferences after the supervised training period in our pooled group, since accumulation of 
visceral  fat  is  known to be  associated  with  a  deterioration  in  blood lipid  profile  (12).  Also 
Ohkawara et al. (24) recently showed a dose-response relationship between visceral fat reduction 
and the amount  of exercise  performed,  showing that about  150 min of moderate  activity per 
week,  exactly  corresponding  to  the  amount  performed  by  our  subjects,  was  necessary  for 
significant visceral fat reduction. The fact that changes in total serum cholesterol correlated with 
changes in TT-performance,  but did not correlate  with changes in body weight, supports the 
evolving notion that blood lipids are mostly affected by level of fitness rather than the level of 
overweight or obesity per se. This is in agreement with a recent study by Tjønna et al.  (32) 
suggesting that increasing aerobic capacity is more important than reducing weight for reducing 
the risk of cardiovascular mortality.
Sleep quality 
Paragraph Number 53 In contrast to the findings of King et al.  (19), Furrer et al. (14) 
and Puhan et  al.  (26), sleep quality remained unchanged after  R+EN and EN. However,  the 
discrepancy  between  the  studies  likely  results  from the  fact  that  these  investigators  studied 
subjects suffering from impaired sleep quality,  while only a few subjects in the present study 
suffered from reduced sleep quality.  Despite the  apnea/hypopnea index  remaining constant in 
both groups, daytime sleepiness tended to improve more with R+EN than with EN alone during 
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the supervised period, the former being associated with a reduced Raw in this group of subjects. 
However,  this  difference  might  result  from the  fact  that  more  R+EN-subjects  (5  vs.  1  EN) 
suffered from excessive daytime sleepiness at baseline. This, in turn, would render RMET more 
likely to improve  these symptoms (14,26).  It  seems,  however,  that  the reduction in  daytime 
sleepiness is independent of the change in energy expenditure, body weight or body fat, while 
the fitness level might affect daytime sleepiness.
Clinical implications
Paragraph Number 54 The fact that the compliance with RMET during the unsupervised 
period was very low, may either mean that the subjects had difficulties continuing with RMET 
without regular contact to a supervisor, or that they were not motivated to continue with RMET 
regularly as long as the level of breathlessness remained reduced. In this context it is important 
to note that, despite the reduction in the amount of RMET performed, subjects of the R+EN-
group at  least  maintained the improvements  attained  after  the supervised period in  the most 
important  parameters  such  as  body  weight  and  exercise  performance.  This  implies  that,  in 
clinical practice, RMET should be supervised initially. As soon as perception of breathlessness is 
markedly reduced, physical training (with or without a reduction in RMET) may be sufficient. 
Limitations of the study
Paragraph Number 55 A first potential limitation is that the EN-group did not perform 
sham training before starting the 3-month EN-period. We decided that if EN-subjects did not 
know about the R+EN-group, their performance 4 months after the start of the program would 
not be affected by this. In addition, they also had regular contact to the experimenters within the 
first  1-month  period  performing  'baseline'  tests  in  the  laboratory.  Second,  blinding  of  the 
experimenters was not possible due to restrictions in personnell. As previous studies showed that 
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a blinded experimenter will know the group-assignment of the subject after the RET, it would 
have meant to have three different experimenters for RET measurements. This would, in turn, 
have  had  the  drawback  of  changing  experimenters  of  the  same  test.  However,  as  the 
experimenters were well aware of the potential  influence of knowing group assignment, they 
payed great attention to treat every subject similarly. Also, subjects were not encouraged during 
exercise tests to limit any expectational influence of the experimenters. A third point is that no 
objective measure of respiratory muscle fatigue, e.g. phrenic nerve stimulation with assessment 
of transdiaphragmatic  pressure,  was performed in this  study.  We refrained from doing these 
time-consuming and rather unpleasant tests because the training and testing load was already 
very high,  in particular  for this  special  group of subjects.  A fourth point  is  that  we did not 
exclude variation in menstrual cycle, i.e. women did not perform each particular test at the same 
time within their respective menstrual cycle in the six different testing periods. We decided not 
to do so for two reasons: i) we wanted to keep the volume of training and the between-test period 
similar  between  subjects  rather  than  having  different  volumes  of  training  or  having  similar 
amounts of training spread over a different time span (since cycle-length is very individual) and 
ii) it would have been almost impossible to schedule the tests given the number of subjects and 
the number of tests per subject. Retrospectively we found that days within the menstrual cycle 
were evenly distributed within each testing period such that we believe this limitation did not 
affect our results. 
Conclusion
Paragraph Number 56 In overweight and obese subjects perceiving a significant amount 
of  breathlessness  during  exercise,  one  month  of  RMET  prior  to  the  start  of  the  3-month 
supervised  EN-intervention  reduced  breathlessness  during  exertion  and  increased  running 
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performance more than EN alone. Reduced breathlessness was associated with increased daily 
physical activity and daily energy expenditure. The change in lifestyle (increased activity and 
reduced energy intake) improved the blood lipid profile in subjects with pathologic values at the 
beginning of the study. The benefits of the supervised period could be preserved independent of 
the training regime and despite decreased compliance in both groups. Therefore, RMET can be 
recommended prior to the start of a lifestyle intervention in overweight and obese subjects to 
enhance benefits of physical fitness.
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Figure legends
FIGURE 1. Study design.
RMET: respiratory muscle endurance training; EN: exercise and nutrition counseling 
program; R+EN: RMET+EN.
FIGURE 2. Details of the different testing sessions.
FIGURE 3. Body weight, maximal workload ( maxW ) and 12-min time trial distance at baseline, 
during and after the R+EN- and EN-intervention-period. R+EN: respiratory muscle endurance 
training + exercise nutrition counseling program; EN: exercise nutrition counseling program. 
Values are given as mean ± SE. Significances are given for comparisons within groups for the 
supervised period (baseline - 4th month, n=15 for R+EN and n=11 for EN) and the unsupervised 
period (4th - 7th month, n=14 for R+EN, n=11 for EN) and for comparisons between changes of 
the two groups within the supervised and unsupervised period (#p < 0.1, *p < 0.05, **p < 0.01, 
***p < 0.001).AC
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Figure 1
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TABLE 1. Anthropometric data, energy intake and energy expenditure
 (n=15)            R+EN            (n=14) (n=11)              EN              (n=11)
baseline 4 months 4 months 7 months ∆ ∆ baseline 4 months 4 months 7 months
supervised unsupervised sup unsup supervised unsupervised
                  
BMI [kg· m-2] 31.2 ± 4.68 29.7 ± 4.5**0 29.6 ± 4.70 29.0 ± 5.3#0   31.6 ± 5.40 30.3 ± 5.8**0 30.3 ± 5.80 29.7 ± 6.1*0
       
Body fat (Peterson) [%] 40.4 ± 4.88 39.4 ± 5.0**0 40.2 ± 4.00 39.3 ± 4.5*0   38.8 ± 6.10 37.4 ± 6.5#*0 37.4 ± 6.50 36.9 ± 6.70*
       
Body fat (DEXA) [%] 36.5 ± 5.38   33.3 ± 5.3§0   36.8 ± 6.20   33.7 ± 7.5§0
       
Waist circumference [m] 1.00 ± 0.14 0.95 ± 0.12**  0.92 ± 0.10 0.91 ± 0.10*   1.04 ± 0.16 1.03 ± 0.16** 1.03 ± 0.17 1.02 ± 0.19*
       
Hip circumference [m] 1.16 ± 0.10 1.12 ± 0.11** 1.10 ± 0.09 1.10 ± 0.10*   1.15 ± 0.10 1.10 ± 0.11** 1.11 ± 0.11 1.10 ± 0.11*
Energy intake [MJ· day-1] 8.7 ± 2.1 6.3 ± 2.1** 6.2 ± 2.1 6.4 ± 2.2*   8.8 ± 2.3 6.7 ± 1.9** 6.7 ± 1.9 6.6 ± 1.7*
Fat intake [g· day-1]   83 ± 240   54 ± 20**0   53 ± 210   57 ± 190*     80 ± 230   60 ± 20*0*   60 ± 200   56 ± 160*
Carbohydrate intake [g· day-1] 243 ± 670 185 ± 61**0 180 ± 600 189 ± 720*   260 ± 780 192 ± 62*0* 192 ± 620 196 ± 600*
Protein intake [g· day-1]   72 ± 180   60 ± 15**0   59 ± 160   58 ± 210*     77 ± 190   60 ± 22*0*   60 ± 220   58 ± 200*
Energy expenditure [MJ· day-1] 11.6 ± 3.20 12.7 ± 3.6**0 12.1 ± 2.60 12.2 ± 2.7*0  11.9 ± 3.30 12.5 ± 3.0*0* 12.5 ± 3.00 11.4 ± 2.6*0
Duration active [h· day-1] 15.4 ± 0.70 15.1 ± 1.5**0 14.8 ± 1.40 14.8 ± 1.70* 15.2 ± 1.20 15.8 ± 1.0*0* 15.8 ± 1.00 15.8 ± 0.90*
Duration ≥ moderately active 
   [min· day-1] 47.7 ± 18.0 64.1 ± 28.1** 67.2 ± 27.6 70.0 ± 26.6* 49.4 ± 16.3 65.5 ± 54.5** 68.3 ± 56.9 56.4 ± 20.1*
           
R+EN: respiratory muscle endurance training and exercise nutrition counseling programme; EN: exercise nutrition counseling programme; BMI: body mass index; DEXA: 
dual-energy X-ray absorptiometry. Values are given as mean ± SD. Significances are given for comparisons within groups for the supervised period (baseline - 4 th month) 
and the unsupervised period (4th - 7th month) and for comparisons between changes (∆) of the two groups within the supervised (sup) and unsupervised (unsup) period (#p < 
0.1, *p < 0.05, **p < 0.01) except for body fat (DEXA) which was compared at baseline and 7 months (§p < 0.05).
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TABLE 2. Incremental cycling (last 3 iso-stages) and 12-min time trial data
 (n=15)            R+EN            (n=14) (n=11)              EN              (n=11)
baseline 4 months 4 months 7 months ∆ ∆ baseline 4 months 4 months 7 months
supervised unsupervised sup unsup supervised unsupervised
           
Incremental cycling test (ICT)
·        
VE  [L· min-1]   69 ± 18   62 ± 16***   63 ± 24   64 ± 15*     66 ± 24   60 ± 20***   64 ± 24   64 ± 25
       
Breathlessness [points]   5.1 ± 2.1   3.9 ± 2.9***   3.6 ± 3.0   3.7 ± 3.5*     4.0 ± 1.9   3.4 ± 2.6***   3.9 ± 2.2   3.8 ± 2.3
       
Respiratory exertion [points]   6.0 ± 1.4   5.2 ± 2.2***   5.4 ± 2.2   5.3 ± 2.2*     5.1 ± 1.8   5.0 ± 2.2***   5.5 ± 2.0   5.4 ± 2.0
       
Leg exertion [points]   6.4 ± 1.4   6.8 ± 1.7***   6.9 ± 1.5   6.8 ± 1.8*    4.7 ± 1.8   5.0 ± 2.0***   5.5 ± 1.9   5.4 ± 2.0
      
Heart rate [beats· min-1] 163 ± 14 151 ± 14*** 154 ± 15 156 ± 14*  159 ± 11 150 ± 11*** 153 ± 13 152 ± 12
      
La [mmol· L-1]   5.9 ± 1.2   4.6 ± 1.1***   5.0 ± 1.8   5.4 ± 1.4*     5.5 ± 2.0   4.0 ± 1.5***   4.5 ± 1.8   4.5 ± 1.4
           
Walk/run Time trial (TT)
·
VE  [L· min-1]   86 ± 23   88 ± 21***   87 ± 22   86 ± 20* *    90 ± 26   83 ± 24***   83 ± 24   83 ± 25
Breathlessness [points]   5.6 ± 1.9   5.0 ± 2.0***   4.9 ± 2.1   4.6 ± 2.8*     5.9 ± 1.6   4.5 ± 2.3***   4.5 ± 2.3   4.1 ± 2.4
Respiratory exertion [points]   6.2 ± 1.2   5.8 ± 1.2***   5.7 ± 1.3   5.6 ± 1.9*    6.9 ± 1.1   5.8 ± 1.5***   5.8 ± 1.5   5.5 ± 1.6
Leg exertion [points]   5.7 ± 1.4   5.9 ± 1.0***   5.7 ± 1.0   5.6 ± 1.9*    6.3 ± 1.7   5.3 ± 1.8***   5.3 ± 1.8   5.3 ± 1.9
Heart rate [beats· min-1]   167 ± 111   165 ± 10***1   164 ± 101   166 ± 991*    166 ± 716   160 ± 10***1   160 ± 100   163 ± 900
La [mmol· L-1]   8.8 ± 3.3   8.0 ± 2.2***   8.2 ± 2.3   8.3 ± 2.6* *    8.7 ± 2.5   6.1 ± 2.6***   6.1 ± 2.6   6.2 ± 2.7
6-min distance 1th run [m]   888 ± 148   938 ± 142***   919 ± 143   929 ± 154* **    888 ± 143   875 ± 150***   875 ± 150   890 ± 180
6-min diistance 2nd run [m]   789 ± 126   885 ± 125***   866 ± 123   878 ± 155*     750 ± 115   823 ± 143***   823 ± 143   822 ± 163
R+EN: respiratory muscle endurance training and exercise nutrition counseling program; EN: exercise nutrition counseling program;   
€  
Ý  V E : minute ventilation; La: blood lactate 
concentration.  Incremental cycling test: 6-min-averages of the last 3 iso-stages; 12-min time trial: 12-min averages. Values are given as mean ± SD. Significances are given 
for comparisons within groups for the supervised period (baseline - 4th month) and the unsupervised period (4th - 7th month) and for comparisons between changes (∆) of the 
two groups within the supervised (sup) and unsupervised (unsup) period (*p < 0.05, **p < 0.01, *** p < 0.001). Note: The last 3 iso-stages differed between comparisons in 
the supervised and unsupervised period. 
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TABLE 3. Quality of life and daytime sleepiness.
 (n=15)            R+EN            (n=14) (n=11)              EN              (n=11)
baseline 4 months 4 months 7 months ∆ ∆ baseline 4 months 4 months 7 months
supervised unsupervised sup unsup supervised unsupervised
                  
Daytime sleepiness [points]   9.3 ± 4.10   7.2 ± 3.4**   7.3 ± 3.5   7.6 ± 3.5 # #   6.7 ± 3.70 7.2 ± 4.0**   7.2 ± 4.0   5.9 ± 3.1#
Physical component summary [score] 49 ± 50 54 ± 4** 54 ± 4 53 ± 8   50 ± 60 53 ± 6**0 53 ± 6 55 ± 4*
       
Mental component summary [score] 46 ± 11   48 ± 10**   47 ± 10   48 ± 12     47 ± 100   47 ± 12*0*   47 ± 12   46 ± 11*
Breathlessness [points] 1.3 ± 1.1   1.4 ± 1.4** 0.6 ± 0.7 0.9 ± 1.8**
Wellbeing [points] 6.3 ± 1.6   6.6 ± 1.7** 5.9 ± 1.6 7.2 ± 1.9**
Tiredness [points] 4.3 ± 1.3   3.2 ± 1.7** 3.6 ± 1.8 2.6 ± 2.2#*
Hunger [points] 2.9 ± 1.2   3.2 ± 1.7** 2.5 ± 1.4 2.1 ± 1.6**
           
R+EN: respiratory muscle endurance training and exercise nutrition counseling program; EN: exercise nutrition counseling program. SF-36 norm values for demographics of 
our  population:  physical  component  summary (median [25th-75th percentile]):  (54 [47-57]);  mental  component  summary (53 [48-56]).  Values  are  given as mean ± SD. 
Significances are given for comparisons within groups for the supervised period (baseline - 4th month) and the unsupervised period (4th - 7th month) and for comparisons 
between changes (∆) of the two groups within the supervised (sup) and unsupervised (unsup) period (#p < 0.1, *p < 0.05, **p < 0.01). 
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TABLE 4. Metabolic blood analyses
 (n=15)            R+EN            (n=14) (n=11)              EN              (n=11)
baseline 4 months 4 months 7 months ∆ ∆ baseline 4 months 4 months 7 months
supervised unsupervised sup unsup supervised unsupervised
                  
Glucose [mmol· L-1] 5.0 ± 0.4 5.2 ± 0.4* 5.2 ± 0.4 5.2 ± 0.5*    5.1 ± 0.4   5.1 ± 0.4**   5.1 ± 0.4   5.1 ± 0.4
      
Total serum cholesterol [mmol· L-1] 5.0 ± 0.9 4.9 ± 1.1* 4.9 ± 1.1 4.9 ± 0.9*    4.9 ± 0.8   4.6 ± 0.9**   4.6 ± 0.9   4.9 ± 1.0
      
HDL-cholesterol [mmol· L-1] 1.5 ± 0.3 1.4 ± 0.2* 1.4 ± 0.3 1.5 ± 0.3*    1.5 ± 0.5   1.4 ± 0.5**   1.4 ± 0.5   1.6 ± 0.6
      
LDL-cholesterol [mmol· L-1l] 3.0 ± 0.9 3.1 ± 1.0* 3.1 ± 1.1 2.9 ± 0.9*     2.8 ± 0.9   2.5 ± 0.9**   2.5 ± 0.9   2.6 ± 1.0
       
Total serum triglycerides [mmol· L-1] 1.0 ± 0.4 1.0 ± 0.3* 1.0 ± 0.3 0.9 ± 0.3*     1.5 ± 0.8   1.4 ± 0.6**   1.4 ± 0.6   1.5 ± 0.9
       
Insulin [mIU· L-1] 6.8 ± 2.6 6.4 ± 2.4* 6.5 ± 2.5 8.2 ± 3.1*  10.7 ± 3.2 11.8 ± 6.2** 11.8 ± 6.2 10.4 ± 6.0
           
R+EN: respiratory muscle endurance training and exercise nutrition counseling programme; EN: exercise nutrition counseling programme; HDL: high-density lipoprotein; LDL: 
low-density lipoprotein. Values are given as mean ± SD. Significances are given for comparisons within groups for the supervised period (baseline - 4th month) and the 
unsupervised period  (4th - 7th month) and for comparisons between changes (∆) of the two groups within the supervised (sup) and unsupervised (unsup) period (*p < 0.05, 
**p < 0.01).
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 TABLE 5. Lung function, respiratory muscle strength and respiratory muscle endurance test data
 (n=15)            R+EN            (n=14) (n=11)              EN              (n=11)
baseline 4 months 4 months 7 months ∆ ∆ baseline 4 months 4 months 7 months
supervised unsupervised sup unsup supervised unsupervised
                  
VC [% pred] 120 ± 13 123 ± 13***8 124 ± 138 124 ± 15*8 113 ± 19   110 ± 11**   110 ± 118   112 ± 1288
     
FEV1 [% pred] 108 ± 13 111 ± 15**8* 113 ± 158 111 ± 15*8 101 ± 11 100 ± 9** 100 ± 98 101 ± 888
     
PEF [% pred]   99 ± 16 100 ± 16**8* 101 ± 168 102 ± 158*   95 ± 15     98 ± 13**     98 ± 138     99 ± 1388
     
MVV [% pred] 119 ± 20 129 ± 25**8* 132 ± 218 134 ± 198* 114 ± 17   120 ± 16**   120 ± 168   119 ± 1988
       
Raw  [% pred] 137 ± 41 121 ± 39**8* 119 ± 408 131 ± 458*  * 150 ± 32   143 ± 31**   143 ± 318   125 ± 2588
       
PImax [% pred] 120 ± 23 127 ± 26**8* 127 ± 288 126 ± 28*8   110 ± 26   129 ± 33**   124 ± 318   130 ± 3288
       
PEmax  [% pred] 103 ± 22   96 ± 23***8   94 ± 238   97 ± 258* *    88 ± 22   100 ± 33**     98 ± 328     98 ± 2888
Respiratory muscle endurance test (RET)
Breathing duration [min] 12.8 ± 4.1 46.8 ± 11.8*** 46.7 ± 12.2 40.4 ± 17.9* *** ** 13.3 ± 5.6   27.4 ± 15.3   27.4 ± 15.3 33.8 ± 17.7
Breathlessness [points]   4.0 ± 2.3 1.4 ± 1.4*** 1.4 ± 1.5 1.8 ± 2.1* * **   3.9 ± 2.2   3.3 ± 2.4   3.3 ± 2.4 2.5 ± 2.4
Respiratory exertion [points]   6.6 ± 1.8 3.0 ± 1.7*** 3.1 ± 1.8 3.4 ± 2.3* *** *   6.0 ± 1.6   5.3 ± 2.1   5.3 ± 2.1 4.4 ± 2.2 
Heart rate [beats· min-1] 102 ± 18 90 ± 14*** 90 ± 14 91 ± 15*   109 ± 10      99 ± 14**   99 ± 14 99 ± 15
La [mmol· L-1]   1.9 ± 0.7 1.3 ± 0.4*** 1.3 ± 0.4 1.5 ± 0.7*     1.8 ± 0.7   1.5 ± 0.4   1.5 ± 0.4 1.5 ± 0.4
Raw,∆ [kPa· L-1· s-1]   0.20 ± 0.60 0.08 ± 0.13*** 0.08 ± 0.14 0.04 ± 0.17*   0.08 ± 0.12 .-0.03 ± 0.17 .-0.02 ± 0.16 0.05 ± 0.07
           
R+EN: respiratory muscle endurance training and exercise nutrition counseling program; EN: exercise nutrition counseling program; VC: vital capacity; pred: predicted; FEV1: 
forced expiratory volume in 1 s; PEF: peak expiratory flow rate; MVV: maximum voluntary ventilation during 12 s; Raw: airway resistance; PImax: maximal inspiratory mouth 
pressure; PEmax: maximal expiratory mouth pressure; La: blood lactate concentration; Raw,∆: change in airway resistance from rest to isotime in the respiratory endurance test. 
Values are given as mean ± SD. Significances are given for comparisons within groups for the supervised period (baseline - 4th month) and the unsupervised period (4th - 7th 
month) and for comparisons between changes (∆) of the two groups within the supervised (sup) and unsupervised (unsup) period (*p < 0.05, **p < 0.01, ***p < 0.001).
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